Is Aurora Cannabis (TSX:ACB) Stock a Buy After the Market Crash?

After falling dramatically in the stock market crash, is Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) stock a buy?

| More on:
question marks written reminders tickets

Image source: Getty Images

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) stock has been beaten down badly in recent months. It had already been in a bearish trend before the March stock market crash, which proceeded to take it even lower. By April 22, the stock was trading for $1, a price it hadn’t seen since 2016.

Despite all this, the company’s sales have actually been growing. In its most recent quarter, ACB grew its sales compared to the same quarter a year before. The result of this has been ACB getting cheaper–by some metrics–than it had been in years, which doesn’t necessarily make the stock a buy. That said, it may now be worth looking at in light of the latest developments.

Cannabis sales reportedly doing well

One trend that has been benefitting Aurora recently is an increase in legal cannabis sales.

Cannabis is one type of product that may have actually seen its sales increase in the COVID-19 era. According to a recent CTV News report, legal cannabis shops in Alberta reported major sales increases in the wake of the pandemic. A similar story in Reuters reported a 100% increase in online orders in Ontario, and a 76% increase in Nova Scotia.

We’ll have to wait on Statistics Canada data to see if there was an aggregate increase in cannabis sales nation-wide, but it looks like they were up in at least some provinces.

These statistics are consistent with long term economic trends. During economic crises, people tend to increase their consumption of “vice” products like alcohol and tobacco. Legal cannabis would certainly be in the same category, making the recent cannabis sales trends in line with similar products.

Aurora’s latest earnings

Aurora’s recent earnings agree with the general observation that cannabis sales are rising nationwide.

In its most recent quarter, Aurora did $63.6 million in sales, up from $59.4 million in the same quarter a year before. These results are for the quarter ended December 31st 2019, so the pandemic was not in full swing yet. Nevertheless, we did see a positive trend in Aurora’s sales.

Earnings, on the other hand, were a different story. In the same quarter that it recorded $63.6 million in sales, Aurora had a $1.3 billion net loss. Granted, that was mostly due to goodwill impairment, which isn’t a cash loss, but even without non-cash charges, the company lost $119 million. That’s a bigger loss than in the same quarter a year before.

So we’ve got a company here that’s simultaneously cheaper than ever relative to sales, but also running bigger losses than ever. This type of stock is hard to value because it’s showing a mix of positive and negative signs.

Foolish takeaway

Despite its lower price relative to sales, I wouldn’t buy Aurora Cannabis stock right now, as the company’s losses just keep getting bigger and bigger. It’s normally for young “growth” companies to lose money, but a trend toward ever larger losses is not a good sign.

Furthermore, any increase in cannabis sales from the economic crisis will be short lived, as the consumption of vice products in recessions tends to fade as the crisis abates.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »